Patent details

Basic Information

Publication number:

EP2311807

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP100079144

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Compounds and composition as protein kinase inhibitors

French Title of Invention:

COMPOSÉS ET COMPOSITIONS INHIBANT LA PROTÉINE KINASE

German Title of Invention:

VERBINDUNGEN UND ZUSAMMENSETZUNGEN ALS PROTEINKINASE-HEMMER

SPC Number:

Dates

Filing date:

20/11/2007

Grant date:

11/11/2015

EP Publication Date:

11/11/2015

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

20/04/2011

EP B1 Publication Date:

11/11/2015

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

20/11/2015

Expiration date:

20/11/2027

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

20/11/2007

 

 

Name:

Novartis AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:

Marsilje Thomas H.

Address:

United States (US)

2

Name:

Jin Yunho

Address:

United States (US)

3

Name:

Pei Wei

Address:

United States (US)

4

Name:

Uno Tetsuo

Address:

United States (US)

5

Name:

Chen Bei

Address:

United States (US)

6

Name:

Jiang Tao

Address:

United States (US)

7

Name:

Michellys Pierre-Yves

Address:

United States (US)

Priority

Priority Number:

869299 P

Priority Date:

08/12/2006

Priority Country:

United States (US)

Classification

Main IPC Class:

C07D 213/74;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages